The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation

In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status of reverse payment cases against pharmaceutical companies. Reverse payment cases arise from settlement agreements between brand-name pharmaceutical firms and generic drug manufacturers to resolve patent litigation under the Hatch-Waxman Act. This legal framework aims to […] Source